INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,027,219 | -40.9% | 92,877 | -28.2% | 0.00% | -33.3% |
| Q1 2023 | $1,737,668 | +310.3% | 129,387 | +277.9% | 0.00% | +200.0% |
| Q4 2022 | $423,499 | -4.4% | 34,236 | +7.8% | 0.00% | 0.0% |
| Q3 2022 | $443,000 | +10.8% | 31,745 | +9.6% | 0.00% | 0.0% |
| Q2 2022 | $400,000 | -16.1% | 28,954 | -1.2% | 0.00% | 0.0% |
| Q1 2022 | $477,000 | -6.7% | 29,310 | -6.7% | 0.00% | 0.0% |
| Q4 2021 | $511,000 | -67.4% | 31,400 | +59.4% | 0.00% | -66.7% |
| Q2 2019 | $1,568,000 | +6.7% | 19,703 | +50.1% | 0.00% | 0.0% |
| Q1 2019 | $1,469,000 | -13.9% | 13,130 | +153.8% | 0.00% | -25.0% |
| Q1 2014 | $1,707,000 | – | 5,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |